ARIMIDEX 1MG FIERCE 50 CAPS

• Prescription ARIMIDEX is just for postmenopausal ladies. ARIMIDEX shouldn’t be taken in case you are pregnant as a result of it could hurt your unborn baby. Don’t take ARIMIDEX 1mg in case you are allergic to any of its components
• Based mostly on info from a examine in sufferers with early breast most cancers, ladies with a historical past of blockages in coronary heart arteries (ischemic coronary heart illness) who take ARIMIDEX might have a slight improve in such a coronary heart illness in comparison with comparable sufferers who take tamoxifen
• ARIMIDEX may cause bone softening/weakening (osteoporosis) rising the possibility of fractures. In a medical examine in early breast most cancers, there have been extra fractures (together with fractures of the backbone, hip, and wrist) with ARIMIDEX (11%) than with tamoxifen (9%)
• In a medical examine in early breast most cancers, some sufferers taking ARIMIDEX 1 mg had a rise in ldl cholesterol. Pores and skin reactions, allergic reactions, and adjustments in blood assessments of liver perform have additionally been reported
• Within the early breast most cancers medical trial, the most typical uncomfortable side effects seen with ARIMIDEX 1mg embrace sizzling flashes, joint signs (together with arthritis and arthralgia), weak point, temper adjustments, ache, again ache, sore throat, nausea and vomiting, rash, melancholy, hypertension, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache.
• In superior breast most cancers trials, the most typical uncomfortable side effects seen with ARIMIDEX versus tamoxifen embrace sizzling flashes, nausea, decreased vitality and weak point, ache, again ache, headache, bone ache, elevated cough, shortness of breath, sore throat, and swelling of legs and arms. Joint ache/stiffness has been reported in affiliation with the usage of ARIMIDEX
• ARIMIDEX shouldn’t be taken with tamoxifen or estrogen-containing therapies

ARIMIDEX is accredited for adjuvant therapy (therapy following surgical procedure with or with out radiation) of postmenopausal ladies with hormone receptor-positive early breast most cancers.

ARIMIDEX is accredited for the preliminary therapy of postmenopausal ladies with hormone receptor-positive or hormone receptor-unknown regionally superior or metastatic breast most cancers and for the therapy of postmenopausal ladies with superior breast most cancers that has progressed following therapy with tamoxifen. Sufferers with hormone receptor-negative illness and sufferers who didn’t beforehand reply to tamoxifen remedy not often responded to ARIMIDEX.